Shanghai Gross Profit from 2010 to 2024

688293 Stock   42.98  0.20  0.47%   
Shanghai OPM's Gross Profit is increasing over the years with slightly volatile fluctuation. Gross Profit is expected to dwindle to about 142 M. Gross Profit is the profit Shanghai OPM Biosciences makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals
 
Gross Profit  
First Reported
2010-12-31
Previous Quarter
143.1 M
Current Value
142 M
Quarterly Volatility
44.2 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Shanghai OPM financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Shanghai OPM's main balance sheet or income statement drivers, such as Net Interest Income of 20.9 M, Interest Income of 12.1 M or Interest Expense of 4.2 M, as well as many indicators such as . Shanghai financial statements analysis is a perfect complement when working with Shanghai OPM Valuation or Volatility modules.
  
This module can also supplement various Shanghai OPM Technical models . Check out the analysis of Shanghai OPM Correlation against competitors.

Currently Active Assets on Macroaxis

Other Information on Investing in Shanghai Stock

Shanghai OPM financial ratios help investors to determine whether Shanghai Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shanghai with respect to the benefits of owning Shanghai OPM security.